We know the drug reduces body weight, but up until now, no one has shown in any group of patients with overweight and obesity that the risk for cardiovascular events could be reduced. Dr
How does PlexusDx keep costs flat while allowing proper dose increases
Wegovy (Semaglutide for Chronic Weight Management) FDA indication: Chronic weight management in adults with BMI 30 or greater, or BMI 27 or greater with at least one weight-related comorbidity Approved doses: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg (weekly subcutaneous injection) Target maintenance dose: 2.4 mg weekly Pediatric indication: Approved for adolescents aged 12 and older with obesity Ozempic (Semaglutide for Type 2 Diabetes) FDA indication: Adjunct to diet and exercise for glycemic control in adults with type 2 diabetes Approved doses: 0.25 mg, 0.5 mg, 1.0 mg, 2.0 mg (weekly subcutaneous injection) Note: Not FDA-approved for weight management, though frequently prescribed off-label Rybelsus (Oral Semaglutide) FDA indication: Type 2 diabetes management Doses: 3 mg, 7 mg, 14 mg (daily oral tablet) Lower bioavailability: Oral formulation has approximately 1% bioavailability, resulting in less predictable weight loss compared to injectable forms Comprehensive semaglutide training for physicians emphasizes the importance of prescribing the correct formulation for the correct indication
In June 2025, Eli Lilly announced that its highest approved doses of Zepbound (12.5 mg and 15 mg) would be made available in single-dose vials for USD 499/month through LillyDirects Self Pay Journey Program
SGLT2 inhibitor or GLP-1 receptor agonist in type 2 diabetes
It communicates with the brain, too particularly regions also responsible for processing smell When scent molecules bind to receptors in the nose, they send electrical signals to the olfactory bulb, which in turn relays information to the brain
